Cargando…
DA-9701 (Motilitone): A Multi-Targeting Botanical Drug for the Treatment of Functional Dyspepsia
Functional dyspepsia (FD) is the most common functional gastrointestinal disorder (FGID). FD is characterized by bothersome symptoms such as postprandial fullness, early satiety, and epigastric pain or burning sensations in the upper abdomen. The complexity and heterogeneity of FD pathophysiology, w...
Autores principales: | Jin, Mirim, Son, Miwon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321359/ https://www.ncbi.nlm.nih.gov/pubmed/30551633 http://dx.doi.org/10.3390/ijms19124035 |
Ejemplares similares
-
DA-9701: A New Multi-Acting Drug for the Treatment of Functional Dyspepsia
por: Kwon, Yong Sam, et al.
Publicado: (2013) -
Efficacy of DA-9701 (Motilitone) in Functional Dyspepsia Compared to Pantoprazole: A Multicenter, Randomized, Double-blind, Non-inferiority Study
por: Jung, Hye-Kyung, et al.
Publicado: (2016) -
A Randomized, Double-blinded, Placebo-controlled Study to Evaluate the Efficacy and Safety of DA-9701 (Motilitone) in Patients With Constipation-type Irritable Bowel Syndrome and Functional Dyspepsia Overlap: A Pilot Study
por: Lee, Ju Yup, et al.
Publicado: (2022) -
Effect of DA-9701 on Colorectal Distension-Induced Visceral Hypersensitivity in a Rat Model
por: Kim, Eun Ran, et al.
Publicado: (2014) -
Randomized, Controlled, Multi-center Trial: Comparing the Safety and Efficacy of DA-9701 and Itopride Hydrochloride in Patients With Functional Dyspepsia
por: Choi, Myung-Gyu, et al.
Publicado: (2015)